These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7751856)

  • 1. Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination.
    Salvetti M; Pisani A; Bastianello S; Millefiorini E; Buttinelli C; Pozzilli C
    J Neurol; 1995 Feb; 242(3):143-6. PubMed ID: 7751856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of gadolinium-enhanced images on a follow-up magnetic resonance image in suspected multiple sclerosis.
    Moore FG; Levental M
    Can Assoc Radiol J; 2013 Nov; 64(4):358-62. PubMed ID: 23267520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration.
    Thompson AJ; Miller D; Youl B; MacManus D; Moore S; Kingsley D; Kendall B; Feinstein A; McDonald WI
    Neurology; 1992 Jan; 42(1):60-3. PubMed ID: 1734325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis.
    Bastianello S; Pozzilli C; Bernardi S; Bozzao L; Fantozzi LM; Buttinelli C; Fieschi C
    Neurology; 1990 Apr; 40(4):591-5. PubMed ID: 2320230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis.
    De Keyser J; Zwanikken C; Boon M
    J Neurol Sci; 1998 Jul; 159(1):51-3. PubMed ID: 9700703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis.
    Koudriavtseva T; Thompson AJ; Fiorelli M; Gasperini C; Bastianello S; Bozzao A; Paolillo A; Pisani A; Galgani S; Pozzilli C
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):285-7. PubMed ID: 9069488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis.
    Tortorella C; Bellacosa A; Paolicelli D; Fuiani A; Di Monte E; Simone IL; Giaquinto P; Livrea P; Trojano M
    J Neurol Sci; 2005 Dec; 239(1):95-9. PubMed ID: 16209877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.
    Filippi M; Rovaris M; Capra R; Gasperini C; Yousry TA; Sormani MP; Prandini F; Horsfield MA; Martinelli V; Bastianello S; Kühne I; Pozzilli C; Comi G
    Brain; 1998 Oct; 121 ( Pt 10)():2011-20. PubMed ID: 9798753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial magnetic resonance imaging studies with paramagnetic contrast medium: assessment of disease activity in patients with multiple sclerosis before and after influenza vaccination.
    Michielsens B; Wilms G; Marchal G; Carton H
    Eur Neurol; 1990; 30(5):258-9. PubMed ID: 2269314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast enhancement and the acute lesion in multiple sclerosis.
    Rovaris M; Filippi M
    Neuroimaging Clin N Am; 2000 Nov; 10(4):705-16 ,viii-ix. PubMed ID: 11359720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging.
    Silver NC; Good CD; Barker GJ; MacManus DG; Thompson AJ; Moseley IF; McDonald WI; Miller DH
    Brain; 1997 Jul; 120 ( Pt 7)():1149-61. PubMed ID: 9236628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial gadolinium-enhanced magnetic resonance imaging in patients with multiple sclerosis treated with mitoxantrone.
    Krapf H; Mauch E; Fetzer U; Laufen H; Kornhuber HH
    Neuroradiology; 1995 Feb; 37(2):113-9. PubMed ID: 7760994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.
    Olberg HK; Cox RJ; Nostbakken JK; Aarseth JH; Vedeler CA; Myhr KM
    Mult Scler; 2014 Jul; 20(8):1074-80. PubMed ID: 24436455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced magnetic resonance imaging in multiple sclerosis.
    Filippi M
    Mult Scler; 2000 Oct; 6(5):320-6. PubMed ID: 11064441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI in the diagnosis and management of multiple sclerosis.
    Arnold DL; Matthews PM
    Neurology; 2002 Apr; 58(8 Suppl 4):S23-31. PubMed ID: 11971123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis.
    Frequin ST; Barkhof F; Lamers KJ; Hommes OR
    J Neuroimmunol; 1992 Oct; 40(2-3):265-72. PubMed ID: 1430156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions.
    Smith ME; Stone LA; Albert PS; Frank JA; Martin R; Armstrong M; Maloni H; McFarlin DE; McFarland HF
    Ann Neurol; 1993 May; 33(5):480-9. PubMed ID: 8498825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The characteristics of enhanced gadolinium DTPA brain magnetic resonance images in 298 multiple sclerosis patients].
    Zhang H; Xu XH; Zhao ZG; Guo H; Qiao LY; Yin J; Hou SF; Wei XF; Wen SG; Geng Y; Jiao YJ; Liu JH; Wang H
    Zhonghua Nei Ke Za Zhi; 2003 Jul; 42(7):490-1. PubMed ID: 12921611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.
    Molyneux PD; Filippi M; Barkhof F; Gasperini C; Yousry TA; Truyen L; Lai HM; Rocca MA; Moseley IF; Miller DH
    Ann Neurol; 1998 Mar; 43(3):332-9. PubMed ID: 9506550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.